Introgen Therapeutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Introgen Therapeutics

INGN 6.890

+0.1%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (720)	5/4/2007 12:49:42 PM
From: Jibacoa	Read Replies (1) of 802

Well, there isn't too much activity in the stock with the scheduled conference for today after the market close.(I don't expect the result will be as good as INAP's CC yesterday.<g>) With DNDN trading again above the $20 level it seems expectations that the FDA will approve Provenge remain high & it seems that the chances for INGN's Advexin will then be much better.<g> The people at the Street.com are already talking about it, comparing it to flipping a coin (they didn't mention if there could be any difference if the flipping is done by a right or left handed guy.<g>) Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next